abstract |
An external preparation for a free radical disease is provided. A transdermal or / and transmucosal external preparation for free radical diseases characterized by containing 3-methyl-1-phenyl-2-pyrazolin-5-one and / or a salt thereof as an active ingredient. . [Selection diagram] None |